Thursday

13th Aug 2020

UK big pharma loses EU court battle over cheaper drugs

UK pharmaceutical firms have been defeated in their attempt to put an end to British government incentives to doctors to supply patients with cheaper but equivalent medicines.

The European Court of Justice rejected a complaint by the Association of the British Pharmaceutical Industry (ABPI) that such National Health Service (NHS) schemes were not an illegal inducement under EU law.

Read and decide

Join EUobserver today

Support quality EU news

Get instant access to all articles — and 20 years of archives. 14-day free trial.

... or subscribe as a group

  • UK health authorities are not seeking commercial advantage by the incentive scheme (Photo: Flickr)

In order to reduce public expenditure, the public health authorities in England and Wales introduced schemes providing doctors with financial incentives to prescribe cheap generic drugs rather than their more expensive patented counterparts.

A 2001 European directive relating to medicinal products prohibits "pecuniary advantages or benefits in kind" from being offered to doctors or pharmacists.

The bill aimed to prevent drug firms from offering incentives such as holidays, golf club memberships or other bonuses for prescribing their product, but in an attempted reversal of the legislation's original intention, the companies argued that rewards to medical practices acted in the same way.

But the court found that the directive was concerned primarily with the promotional activities carried out by the pharmaceutical industry and sought to prevent promotional practices that could push doctors to act more in line with their wallet than a patient's interest.

"By contrast, that prohibition does not apply to national public health authorities which ... do not pursue any profit-making or commercial aim," the court said in its ruling.

"Therefore, the financial incentive scheme examined, which forms part of such a policy, cannot be regarded as seeking the promotion of commercial promotion of medicinal products."

"No danger to public health can be established," the court concluded.

Column

Drums of war again, in Europe

Just a few weeks ago, as Europeans in several countries put their furious debates about masks and corona appsinto higher gear, Turkey and Greece almost came to blows in the Aegean Sea.

Minsk violence prompts talk of EU sanctions

Images of bloody injuries after police attacked protesters with batons and stun grenades marked Belarus' latest sham election, posing questions on EU sanctions.

Opinion

Schrems privacy ruling risks EU's ties to digital world

With more and more trade moving to the digital realm, Europe can ill-afford to cut itself off. Meanwhile, China continues to advance a vision for an internet that is fractured along national boundaries and controlled by governments.

Column

Drums of war again, in Europe

Just a few weeks ago, as Europeans in several countries put their furious debates about masks and corona appsinto higher gear, Turkey and Greece almost came to blows in the Aegean Sea.

Opinion

Schrems privacy ruling risks EU's ties to digital world

With more and more trade moving to the digital realm, Europe can ill-afford to cut itself off. Meanwhile, China continues to advance a vision for an internet that is fractured along national boundaries and controlled by governments.

Stakeholders' Highlights

  1. UNESDANext generation Europe should be green and circular
  2. Nordic Council of MinistersNEW REPORT: Eight in ten people are concerned about climate change
  3. UNESDAHow reducing sugar and calories in soft drinks makes the healthier choice the easy choice
  4. Nordic Council of MinistersGreen energy to power Nordic start after Covid-19
  5. European Sustainable Energy WeekThis year’s EU Sustainable Energy Week (EUSEW) will be held digitally!
  6. Nordic Council of MinistersNordic states are fighting to protect gender equality during corona crisis

Join EUobserver

Support quality EU news

Join us